Nishant Agrawal
@hncancerdoc
Surgeon, scientist, father, dreamer, team-player, and compassionate idealist
ID: 1457768848799633412
08-11-2021 17:56:07
148 Tweet
188 Followers
92 Following
Proud to announce we have been ranked 32 nationally among #ENT programs in the U.S. News & World Report annual report! This is a collective effort reflecting tremendous work and relentless dedication amongst the entire section UChicago Medicine UChicago Surgery uchicagomedicine.org/forefront/news…
AI devices are almost certain to become electronic babysitters—just as previous generations of parents (understandably!) adopted TV as a tool for lightening caregiving duties. Thank you to The Wall Street Journal for letting me weigh in on the peril—and promise—of this. wsj.com/articles/the-a…
ctDNA is a powerful dynamic biomarker with IO-based treatment; Need for prospective ctDNA adaptive immunotherapy trial designs such as our "SINERGY" trial in recurrent/metastatic #headandneckcancer (NCT05420948) Evgeny Izumchenko Aditya Juloori Nishant Agrawal nature.com/articles/s4159…
UChicago Medicine Voice Center spreading some holiday cheer in the sky lobby!! Shout out to UChicago Surgery UChicagoOHNS’s very own Dr. Brandon Baird 🤩😎🎤🎶🎵
So excited that Drs. Roxbury, Baroody, Shogan, Portugal, Pinto, Elizabeth Blair Nishant Agrawal Michael Gluth Dr. Dana Suskind have made the list! Such an incredible honor that reflects their dedication to patient care! 👏🏻🤩🤗 #TopDocs2024 #Chicago #ENT #IamOto UChicago Surgery
Manu Sundaresan, 4th year undergrad student The University of Chicago presents an excellent poster at #AACR24 showing the association of higher levels of PDCD10 expression with poor prognosis in oral squamous cell carcinoma. UChicagoCancerCenter Nishant Agrawal Evgeny Izumchenko
Congratulations to Alka Singh on receiving “AACR Scholar in Training Award” for presenting important work on “Comprehensive characterization of mitochondrial mutational landscape in the evolution of adenocarcinoma.” Nishant Agrawal Evgeny Izumchenko UChicagoCancerCenter UChicagoOHNS
Ari Rosenberg at #asco24 sharing a first look at TARGET-HPV. Exciting HPV targeted chemo-immunotherapy neoadjuvant treatment with adaptive de-escalation. A great multi-D effort from UChicagoCancerCenter University of Chicago Hematology/Oncology UChicagoOHNS University of Chicago Radiation Oncology
Ari Rosenberg presents results from HB-200, an arenavirus-based vector therapy specifically targeted for HPV+ oropharyngeal cancers. Neoadjuvant HB-200 could be a potential new therapy as induces T-cell responses and reduces ctHPV-DNA. #ASCO24 UChicagoCancerCenter UChicago Medicine
Excited that our OPTIMA II trial is out in JAMA Oncology! Neoadjuvant nivo/chemo -> response-adaptive treatment for HPV+ oropharyngeal cancer Everett Vokes Pearson Lab Aditya Juloori Nishant Agrawal Elizabeth Blair Sysmex Inostics UChicagoCancerCenter UChicago Medicine University of Chicago Hematology/Oncology jamanetwork.com/journals/jamao…
Ari Rosenberg #OPTIMA2 HNSCC DE-ESCALATION study out today JAMA Oncology: 🧑🤝🧑Broad inclusion N2 to N3 and/or T3 to T4 HPV+ 🙌Excellent OS 💪Chemo/IO induction has high pathCR rates 👄Super-low g-tube rates for max de-escalated pts (green KM curve line) see: ow.ly/Xmqu50Sb99b
A truly special night celebrating the graduation of our chief residents Drs. Warren and Patel! They were a special duo who will be sorely missed 🥹 They are both off for fellowship Emory Otolaryngology and we look forward to their future accomplishments #ENT #Residency #IamOto
We are proud to announce that UChicagoCancerCenter has been ranked #1 in Illinois and #12 in the nation in the latest U.S. News & World Report's Best Hospitals. We are committed to providing highest quality care to cancer patients. health.usnews.com/best-hospitals…
Experts at UChicago Medicine successfully treated and cured stage IV oral cancer patient Pat Sirvinskas with a unique approach that spared her tongue. Hear her story in her own words. Nishant Agrawal Ari Rosenberg Aditya Juloori UChicagoOHNS ow.ly/ksE550SPooT